The presence of a high incidence of thrombotic events, mainly in nontransfusion-dependent β-thalassemia syndromes, has led to the identification of a hypercoagulable state in thalassemia patients. This article highlights the mechanisms leading to hypercoagulability in thalassemia. It also discusses the clinical experience and available evidence on prevention and management approaches.
Hypercoagulability and Vascular Disease / A.T. Taher, M.D. Cappellini, R. Bou-Fakhredin, D. Coriu, K.M. Musallam. - In: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. - ISSN 0889-8588. - 32:2(2018), pp. 237-245.
Hypercoagulability and Vascular Disease
M.D. CappelliniSecondo
Methodology
;R. Bou-Fakhredin;
2018
Abstract
The presence of a high incidence of thrombotic events, mainly in nontransfusion-dependent β-thalassemia syndromes, has led to the identification of a hypercoagulable state in thalassemia patients. This article highlights the mechanisms leading to hypercoagulability in thalassemia. It also discusses the clinical experience and available evidence on prevention and management approaches.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Taher Cappellini Hypercoagulability 2018.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
304.83 kB
Formato
Adobe PDF
|
304.83 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
